-
1721
-
1722
-
1723
Reward signals in the motor cortex: from biology to neurotechnology
Published 2025-02-01Get full text
Article -
1724
-
1725
Dysphagia in patients with cerebrovascular disease. Update.
Published 2009-03-01“…One of the objectives of the Nutritional Support Team of the Neuroscience and Neurology Institute is to reduce undernourishment causes in patients with neurological diseases. …”
Get full text
Article -
1726
Powering the Immune System: Mitochondria in Immune Function and Deficiency
Published 2014-01-01Get full text
Article -
1727
Identifying the Effective Factors on Neuropathic Diseases in Patients with Chronic pain Using Deep Neural Networks
Published 2020-09-01“…In this research, pain questionnaire of Shafa Neuroscience Research Center in Khatam-ol-Anbia Hospital in Tehran is study. …”
Get full text
Article -
1728
Identification of Molecular Signatures in Neural Differentiation and Neurological Diseases Using Digital Color-Coded Molecular Barcoding
Published 2020-01-01“…Here, we review the literature on the development and application of digital color-coded molecular barcoding as a potential tool for standardizing PSC research and applications in neuroscience. We will also describe relevant examples of the use of this technique for the characterization of the heterogeneous composition of the brain tumor glioblastoma multiforme.…”
Get full text
Article -
1729
Convergence of Synapses, Endosomes, and Prions in the Biology of Neurodegenerative Diseases
Published 2013-01-01Get full text
Article -
1730
-
1731
-
1732
IGF-1 impacts neocortical interneuron connectivity in epileptic spasm generation and resolution
Published 2025-01-01Get full text
Article -
1733
Lipid trajectories improve risk models for Alzheimer’s disease and mild cognitive impairment
Published 2025-01-01Get full text
Article -
1734
-
1735
-
1736
Improving the integrity and reproducibility of research that uses antibodies: a technical, data sharing, behavioral and policy challenge
Published 2024-12-01“…The open-science company YCharOS works with major antibody manufacturers and knockout cell line producers to characterize antibodies, identifying high-performing renewable antibodies for many targets in neuroscience. This shows the progress that can be made by stakeholders working together. …”
Get full text
Article -
1737
Predicting conversion to psychosis using machine learning: response to Cannon
Published 2025-01-01Get full text
Article -
1738
Hydrophobic and Hydrophilic IOLs in Patients with Uveitis – A Randomised Clinical Trial
Published 2025-02-01“…Sara Pålsson,1,2 Claes Schuborg,2,3 Bertil Sterner,1,2 Marita Andersson Grönlund,1,4 Madeleine Zetterberg1,2 1Department of Clinical Neuroscience/Ophthalmology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; 2Region Västra Götaland, Sahlgrenska University Hospital, Department of Ophthalmology, Mölndal, Sweden; 3Guldhedskliniken, Gothenburg, Sweden; 4Department of Ophthalmology, Faculty of Medicine and Health, Örebro University, Örebro, SwedenCorrespondence: Madeleine Zetterberg, Sahlgrenska University Hospital, Department of Ophthalmology, Mölndal, SE 431 80, Sweden, Tel +46 31 33 43 31 50, Fax +46 31 41 29 04, Email madeleine.zetterberg@vgregion.sePurpose: To compare inflammatory response, visual acuity, and complications of two intraocular lenses (IOLs) in patients with and without uveitis.Setting: Tertiary referral centre at Sahlgrenska University Hospital/Mölndal, Sweden.Design: Prospective randomised controlled trial.Patients and Methods: Patients with and without uveitis eligible for cataract surgery were randomised to receive a hydrophobic or a hydrophilic square-edged intraocular lens (IOL). …”
Get full text
Article -
1739
Global variation in the assessment of psychological trauma in pregnancy
Published 2025-01-01Get full text
Article -
1740
Clinical and Imaging Features of Familial and Sporadic Multiple Sclerosis
Published 2025-01-01Get full text
Article